Product Information
DEFERASIROX 360 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $1.4953 per EA under NDC 72603023301. Its NADAC has been published 91 times since Oct 2, 2024.
Strength
360 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603023301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEFERASIROXApproval Type
Generic (ANDA)
FDA Application
ANDA214474On Market Since
10/16/2023
Pharmacological Classes
Price Statistics
The NADAC for DEFERASIROX 360 MG TABLET has been published 91 times since Oct 2, 2024, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4953 per EA |
|---|---|
| All-time high | $1.9511 (Oct 16, 2024) |
| All-time low | $1.2249 (Nov 19, 2025) |
| 52-week high | $1.6434 |
| 52-week low | $1.2249 |
| Median price | $1.4107 |
| Average price | $1.4764 |
| Largest weekly change | +29.6% (Mar 18, 2026) |
| Weeks tracked | 91 |
| Tracking since | Oct 2, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEFERASIROX 360 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEFERASIROX 360 MG TABLET, manufactured by NorthStar Rx LLC, is $1.4953 per EA (NDC 72603023301), effective Jun 24, 2026.
How has the price of DEFERASIROX 360 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEFERASIROX 360 MG TABLET has declined 23.4%. It has been tracked across 91 weekly CMS publications since Oct 2, 2024.
What are the highest and lowest recorded NADAC prices for DEFERASIROX 360 MG TABLET?
Since Oct 2, 2024, the NADAC for DEFERASIROX 360 MG TABLET has ranged from a low of $1.2249 (Nov 19, 2025) to a high of $1.9511 (Oct 16, 2024), with a median of $1.4107 per EA.
Are there cheaper alternatives to DEFERASIROX 360 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DEFERASIROX 360 MG TABLET, but none are currently priced below it.
Who manufactures DEFERASIROX 360 MG TABLET?
DEFERASIROX 360 MG TABLET (NDC 72603023301) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification